BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 26070699)

  • 1. Randomized controlled trial of insulin detemir versus NPH for the treatment of pregnant women with diabetes.
    Herrera KM; Rosenn BM; Foroutan J; Bimson BE; Al Ibraheemi Z; Moshier EL; Brustman LE
    Am J Obstet Gynecol; 2015 Sep; 213(3):426.e1-7. PubMed ID: 26070699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes.
    Mathiesen ER; Hod M; Ivanisevic M; Duran Garcia S; Brøndsted L; Jovanovic L; Damm P; McCance DR;
    Diabetes Care; 2012 Oct; 35(10):2012-7. PubMed ID: 22851598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
    Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial comparing perinatal outcomes using insulin detemir or neutral protamine Hagedorn in type 1 diabetes.
    Hod M; Mathiesen ER; Jovanovič L; McCance DR; Ivanisevic M; Durán-Garcia S; Brøndsted L; Nazeri A; Damm P
    J Matern Fetal Neonatal Med; 2014 Jan; 27(1):7-13. PubMed ID: 23617228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detemir vs neutral protamine Hagedorn insulin for diabetes mellitus in pregnancy: a comparative effectiveness, randomized controlled trial.
    Fishel Bartal M; Ward C; Blackwell SC; Ashby Cornthwaite JA; Zhang C; Refuerzo JS; Pedroza C; Lee KH; Chauhan SP; Sibai BM
    Am J Obstet Gynecol; 2021 Jul; 225(1):87.e1-87.e10. PubMed ID: 33865836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes.
    Umpierrez GE; Hor T; Smiley D; Temponi A; Umpierrez D; Ceron M; Munoz C; Newton C; Peng L; Baldwin D
    J Clin Endocrinol Metab; 2009 Feb; 94(2):564-9. PubMed ID: 19017758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Hypoglycemia and Safety Outcomes With Long-Acting Insulins Versus Insulin NPH in Pregestational and Gestational Diabetes.
    Sleeman A; Odom J; Schellinger M
    Ann Pharmacother; 2020 Jul; 54(7):669-675. PubMed ID: 31893932
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparing the efficacy and safety of insulin detemir versus neutral protamine hagedorn insulin in treatment of diabetes during pregnancy: a randomized, controlled study.
    Ji J; He Z; Yang Z; Mi Y; Guo N; Zhao H; Gao J; Ma Z; Luo X; Han Z
    BMJ Open Diabetes Res Care; 2020 Apr; 8(1):. PubMed ID: 32265255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen.
    Russell-Jones D; Simpson R; Hylleberg B; Draeger E; Bolinder J
    Clin Ther; 2004 May; 26(5):724-36. PubMed ID: 15220016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and tolerability of once or twice daily neutral protamine hagedorn insulin in fasting pregnant women with diabetes during Ramadan.
    Nor Azlin MI; Adam R; Sufian SS; Wahab NA; Mustafa N; Kamaruddin NA; Jamil MA
    J Obstet Gynaecol Res; 2011 Feb; 37(2):132-7. PubMed ID: 21159037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar glucose control with basal-bolus regimen of insulin detemir plus insulin aspart and thrice-daily biphasic insulin aspart 30 in insulin-naive patients with type 2 diabetes: Results of a 50-week randomized clinical trial of stepwise insulin intensification.
    Malek R; Ajili F; Assaad-Khalil SH; Shinde A; Chen JW; Van den Berg E
    Diabetes Metab; 2015 Jun; 41(3):223-30. PubMed ID: 25483023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of treatment with insulin detemir and NPH in women with gestational diabetes mellitus: glycemic control and pregnancy outcomes. A retrospective study.
    Kazakou P; Paschou SA; Mitropoulou M; Vasileiou V; Sarantopoulou V; Anastasiou E
    Hormones (Athens); 2023 Dec; 22(4):695-701. PubMed ID: 37775682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal Insulin Analogs versus Neutral Protamine Hagedorn for Type 2 Diabetics.
    Fishel Bartal M; Ward C; Refuerzo JS; Ashimi SS; Joycelyn CA; Chen HY; Chauhan SP; Sibai BM
    Am J Perinatol; 2020 Jan; 37(1):30-36. PubMed ID: 31430822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of insulin detemir and neutral protamine Hagedorn (isophane) insulin in the treatment of diabetes: a systematic review.
    Frier BM; Russell-Jones D; Heise T
    Diabetes Obes Metab; 2013 Nov; 15(11):978-86. PubMed ID: 23551900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with insulin detemir or NPH insulin in children aged 2-5 yr with type 1 diabetes mellitus.
    Thalange N; Bereket A; Larsen J; Hiort LC; Peterkova V
    Pediatr Diabetes; 2011 Nov; 12(7):632-41. PubMed ID: 21418455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of insulin detemir compared to NPH insulin for type 1 and type 2 diabetes mellitus in the Canadian payer setting: modeling analysis.
    Tunis SL; Minshall ME; Conner C; McCormick JI; Kapor J; Yale JF; Groleau D
    Curr Med Res Opin; 2009 May; 25(5):1273-84. PubMed ID: 19366302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial.
    Bartley PC; Bogoev M; Larsen J; Philotheou A
    Diabet Med; 2008 Apr; 25(4):442-9. PubMed ID: 18387078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of insulin detemir compared with NPH insulin in people with type 2 diabetes in Denmark, Finland, Norway, and Sweden.
    Ridderstråle M; Jensen MM; Gjesing RP; Niskanen L
    J Med Econ; 2013; 16(4):468-78. PubMed ID: 23384160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.
    Imbergamo MP; Amato MC; Sciortino G; Gambina M; Accidenti M; Criscimanna A; Giordano C; Galluzzo A
    Clin Ther; 2008 Aug; 30(8):1476-84. PubMed ID: 18803989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of insulin analogues in pregnancy.
    Lambert K; Holt RI
    Diabetes Obes Metab; 2013 Oct; 15(10):888-900. PubMed ID: 23489521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.